Vasculogenic mimicry: current status and future prospects.
about
Role of microRNA-26b in glioma development and its mediated regulation on EphA2Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumorsThe relationship between vasculogenic mimicry and epithelial-mesenchymal transitionsTumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugsBrain tumor-targeted drug delivery strategiesTumor cell plasticity and angiogenesis in human melanomasNumber of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma.HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinomaThe embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts.Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancerRac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell linesNicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaBreast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.Biology and flow cytometry of proangiogenic hematopoietic progenitors cells.Angiogenesis and melanoma - from basic science to clinical trials.IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.The changes of angiogenesis and immune cell infiltration in the intra- and peri-tumoral melanoma microenvironment.A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis.Histone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide3-kinase / ERK-MMP-laminin5γ2 signaling pathwayCirculating angiogenic precursors in idiopathic pulmonary arterial hypertension.Inherent phenotypic plasticity facilitates progression of head and neck cancer: endotheliod characteristics enable angiogenesis and invasionDestruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain gliomaLoss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinomaThalidomide influences growth and vasculogenic mimicry channel formation in melanoma.Effects of HCG on human epithelial ovarian cancer vasculogenic mimicry formation in vivoGeneration of erythroid cells from fibroblasts and cancer cells in vitro and in vivo.A pilot study on acute inflammation and cancer: a new balance between IFN-gamma and TGF-beta in melanoma.HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinomaEnhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases.Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.Pro-angiogenic hematopoietic progenitor cells and endothelial colony-forming cells in pathological angiogenesis of bronchial and pulmonary circulationProgress in tumor vascular normalization for anticancer therapy: challenges and perspectives.Intussusceptive angiogenesis: a biologically relevant form of angiogenesis.MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1.LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells.Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.Melanoma vasculogenic mimicry capillary-like structure formation depends on integrin and calcium signaling.
P2860
Q21135751-64527633-66BC-4D29-8E97-F873F7D45A12Q26749164-AC893503-6B27-4AA2-86FB-04C52F08DC61Q26749398-DB36FE8F-7A34-481B-B60B-8949870D1421Q26777335-8672F759-C766-4B69-8C87-7E7A27566226Q26829741-A62FAFBA-D199-40C0-A60A-B5F1A858CF34Q31052984-3B97DD05-E321-405C-A36F-9AEB94439BAEQ33642824-2465FAAF-0C3C-4389-B2DE-124661F896D8Q33714914-CBD7353C-0A4B-4F76-9FCF-21886EEA52F6Q34109886-AC9B4E82-D32B-4984-9A6A-ADBC3EEEB551Q34207659-CB1CDB87-D49E-4831-9EAD-40B887AC4D22Q34578831-6145CFC4-0038-40F3-8F9F-C38D2553ECD1Q34603154-D3D12738-2102-4DB1-8A51-35A90AC2F616Q34684041-537E33A9-B56E-4061-9A5F-FC7C1C556628Q35168107-45CA6925-20A3-4D62-90F7-D1326489D49CQ35380959-639743A7-36B4-41E7-BE3F-539CB131AFD7Q35529018-4BA9A3BE-D645-427B-A505-F25371E243DDQ35585566-A2229D4E-A427-4451-AC7D-7EC6384119DFQ35746801-F234C219-906C-4587-BC8A-0C76CE6058C9Q35848075-DA16503A-9E54-4371-AB19-494A42F4A486Q35904204-DDF46B74-7149-40E4-8FAD-1F3017268338Q36482251-05F550FC-9691-4B53-A125-93315C29EAECQ36698965-55439B7A-DF40-4F46-9F5A-E987FBF6F37AQ36733548-AF0FAE29-B348-4A0C-AF82-85416B344EAFQ36739034-A43A69B5-A660-4995-9112-2081BE67058AQ36999563-6F32A3EB-A9EB-43DA-901A-57E5AA68249FQ37002749-BA069B67-13DD-40ED-B5CD-4CD94900EF99Q37141535-E96046FA-AF0A-4973-A103-F563977115CEQ37195823-4FF4CB7B-03D5-46D6-8EDB-F66A0FC37C16Q37295329-73D19C38-93C0-4516-9169-9F2DFEF42CFEQ37544152-4D79F0E2-037A-425F-8C24-779ED8250505Q37688504-587D2178-B760-446C-AB18-1C2B1814DA81Q37729026-403E57DF-3BFC-4E33-B440-30B3829149CAQ37907120-B2507417-CE9D-4931-852E-2E3C69BC8DB9Q37998372-4DF24654-60E0-430B-9A6D-9FA438DD5F6DQ38022128-527EC604-DB46-456F-A53C-960724BCBE51Q38840573-4350C090-1A7D-4475-8ABC-EAB5294C8DF5Q38888905-140D4D9A-4861-47D5-9241-1ECC964EA8F9Q39188509-9D90E40F-C5DD-4DF4-AC8F-2B79A41D29EBQ39370428-34418BA3-D5F5-4266-8865-A882C96BF882Q39570473-3FD942BE-B035-4E64-A609-1C0E9493490E
P2860
Vasculogenic mimicry: current status and future prospects.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Vasculogenic mimicry: current status and future prospects.
@ast
Vasculogenic mimicry: current status and future prospects.
@en
Vasculogenic mimicry: current status and future prospects.
@nl
type
label
Vasculogenic mimicry: current status and future prospects.
@ast
Vasculogenic mimicry: current status and future prospects.
@en
Vasculogenic mimicry: current status and future prospects.
@nl
prefLabel
Vasculogenic mimicry: current status and future prospects.
@ast
Vasculogenic mimicry: current status and future prospects.
@en
Vasculogenic mimicry: current status and future prospects.
@nl
P2093
P1433
P1476
Vasculogenic mimicry: current status and future prospects.
@en
P2093
Baocun Sun
Danfang Zhang
Shiwu Zhang
P304
P356
10.1016/J.CANLET.2006.12.036
P407
P577
2007-02-15T00:00:00Z